Navigation Links
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Date:2/11/2009

- Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation -

PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) announced today that the ATHENA trial was published in the New England Journal of Medicine. The trial showed that Multaq(R) (dronedarone), in addition to standard therapy, significantly reduced the risk of first cardiovascular hospitalization or death by 24 percent (31.9% vs. 39.4%, p<0.001) in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions.

Atrial fibrillation is the leading cause of hospitalization for arrhythmia in the US(1) and represents one-third of hospitalizations for arrhythmia in Europe(2). Hospitalization due to AF has increased dramatically (two-to-three fold) in recent years in the US(1). Atrial fibrillation is a complex disease that increases the risk of stroke up to five-fold(3), worsens the prognosis of patients with cardiovascular risk factors(4) and that doubles the risk of mortality(5).

The authors' findings, as reported in the New England Journal of Medicine, showed a significant decrease in the risk of cardiovascular death by 29 per cent (p=0.03) in patients with AF. Multaq significantly decreased the risk of arrhythmic death by 45 per cent (p=0.01) and there were numerically fewer deaths (16 per cent) from any cause in the dronedarone group compared to placebo (p=0.18). First cardiovascular hospitalization was reduced by 26 per cent (p<0.001) in the dronedarone group.

"The ATHENA trial is the first trial to show a reduction in the incidence of cardiovascular hospitalization or death in patients taking an anti-arrhythmic drug for atrial fibrillation<
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
6. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
7. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
8. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
9. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
10. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
11. Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/c8jldk/global_healthcare ) has announced the ... report to their offering. The Global ... and CRM BPO to grow at a CAGR of ... a segment of outsourcing, which consists of subcontracting the ... that has the expertise in the required domains. It ...
(Date:5/27/2015)... LOUIS , May 27, 2015   Mallinckrodt Pharmaceuticals ... will present on Wednesday, June 10, 2015, at the Goldman ... Resort in Rancho Palos Verdes, Calif. ... Mark Trudeau , President and Chief Executive Officer, and ... Investor Relations Officer, will represent the company in a session ...
(Date:5/27/2015)... ATLANTA , May 27, 2015  MT ... which operates lawsuitsettlementnews.com, reports today the most up-to-date ... including Stryker , DePuy, Wright, ... however, certain litigations are still dragging on and ... Stryker Corporation: Stryker Corporation has agreed to pay ...
Breaking Medicine Technology:Global Healthcare BPO Market 2015-2019 - Emergence of Cloud-based BPO in Healthcare with Accenture, Cognizant, Genpact, IBM, TCS, Wipro & Xerox Dominating 2Mallinckrodt To Present At Goldman Sachs 36th Annual Healthcare Conference 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 3
... HERZELIYA, Israel, September 30 Medical device ... round led by 7 Health,Ventures. Previous investors: Ofer ... as well. , ActiViews, ... used,in Computer Tomography (CT), fluoroscopy and Magnetic Resonance ...
... , JERUSALEM, Israel, September 30 ... evaluating carlecortemcel-l, the generic,name of what is widely known ... leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo ... by,Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3
(Date:5/27/2015)... Representatives from Classified Advertising Plus, LLC, ... the American Immigration Lawyers Association (AILA). The conference takes ... booth is #404. , The annual event is billed ... a regular AILA conference attendee, describes it as “kind ... clients to their booth and make fresh friends among ...
(Date:5/27/2015)... 27, 2015 National Healthcare ... award winning web development and interactive marketing ... the launch of its newly redesigned, custom ... National Healthcare Providers, is a physician owned ... the areas of Radiology, Anesthesiology, Emergency and ...
(Date:5/27/2015)... Water, Inc. , an industry ... announced that its elite BG-12000 Body Glove Water ... pass the new NSF/ANSI Standard 401 – Pharmaceuticals: ... that the BG-12000 by Water, Inc. significantly reduces ... chemicals used in manufacturing that are currently found ...
(Date:5/27/2015)... Net Pistol proudly welcomes two new ... , The Mobility Van Store of Lakeland, Florida, is ... the mobility industry. They have a team of trained ... pre-owned wheelchair-accessible van, truck or car. Additionally, they provide ... chairs, three and four-wheel scooters, and manual wheelchairs. , ...
(Date:5/27/2015)... Chicago, IL (PRWEB) May 27, 2015 The ... Chicago office is open for business to better serve ... is in the Jefferson Park neighborhood on the Northwest side ... Chicago. Appointments can be arranged by calling the Chicago ... location for the Advanced Fertility Center of Chicago. The ...
Breaking Medicine News(10 mins):Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:Net Pistol Continues Success Serving Mobility Dealers 2Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2
... in combination with ribavirin for previously untreated children with ... , KENILWORTH, N.J., Dec. 12 ... announced that the U.S. Food and Drug Administration (FDA) ... REBETOL(R) (ribavirin, USP) combination therapy for use in previously ...
... Mich., Dec. 12 Terumo Corporation and Terumo,s,subsidiary, ... entered into an agreement to settle all outstanding ... a number of lawsuits pending,in which each claims ... litigations all,involve methods and devices used in endoscopic ...
... Dignity of a Person), an Instruction from the Vatican Congregation ... arising from biomedical research, provides guidance on how to respect ... said Cardinal Francis George of Chicago, president of the United ... "We welcome the Instruction as theologians, medical personnel, ...
... could also perpetuate more allergies among kids, , , FRIDAY, ... allergies are on the rise, with more and more ... are responding by providing nut-free areas. , But, at ... far, even creating hysteria over potential nut exposures. What,s ...
... up is hard,to do-but with the sixth annual ... all of the tools to help Americans ditch ... 2009. America,s largest and most,comprehensive multiplatform fitness ... provides participants unprecedented resources and,support -- online, on ...
... the launch of ATSU,s Women,s Wellness Program , ... ... noted scientist, author, and stroke survivor, joined A.T. Still University (ATSU) ... Program Nov. 18 at the Hilton Scottsdale Resort and Villas. Dr. ...
Cached Medicine News:Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 2Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 4Health News:Nut Bans in Schools May Be Spurring Hysteria 2Health News:Nut Bans in Schools May Be Spurring Hysteria 3Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 2Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 3Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 4Health News:Jill Bolte Taylor Keynotes ATSU Women's Wellness Luncheon 2Health News:Jill Bolte Taylor Keynotes ATSU Women's Wellness Luncheon 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 15 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Medicine Products: